[Results of immunotherapy with Allergovit preparation of the Allergopharma Company in patients with hypersensitivity to pollen].
It has been examined 72 patients with pollinosis in age from 5 to 38 which had immunotherapy by vaccines Allergovit. This vaccines has been composed to individual patients along there spectrum hypersensitivity to pollen. After one year hyposensibilisation 78.3% had a very good improve but 20.3% good. In them 7 patients had symptoms in the time when has been pollen another plant than they has been vaccine. Only one hadn't improve because he had allergy to many pollen and vaccines which had too much allergen it's not effective.
Hofman
T
T
Centrum Alergologii w Poznaniu.
Kolasińska
B
B
D000293:Adolescent; D000328:Adult; D000485:Allergens / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007167:Immunotherapy; D006255:Rhinitis, Allergic, Seasonal / Q000517:prevention & control*; D016896:Treatment Outcome; D014612:Vaccines; D014614:Vaccines, Synthetic / Q000008:administration & dosage*
D000485:Allergens; D014612:Vaccines; D014614:Vaccines, Synthetic; C099681:allergovit
Wyniki odczulania preparatem Allergovit firmy Allergopharma chorych z nadwrazliwościa na pyłki roślin.